• ENO1, Macrophage Metabolism, and Cardiac Repair

  2026-11-13

  A preclinical study examines ENO1 as a metabolic regulator of inflammatory macrophages after myocardial infarction and tests an acid-responsive nanocarrier for localized siRNA delivery. The findings connect ENO1 silencing with reduced glycolytic activity, altered lactate–KLF4 signaling, macrophage-state changes, and improved structural and functional cardiac readouts in mice.

• SIRT1 Links Bone Vessels and Osteogenesis

  2026-11-12

  A preclinical study links age-associated SIRT1 decline with impaired type H vasculature, osteogenic activity, and endothelial–mesenchymal coordination in bone. Across aged mice and senescent cell models, SIRT1 modulation affected vascular and osteogenic phenotypes, with β-catenin signaling emerging as a candidate molecular intermediary.

• Annexin V Readouts in ENO1 Cardiac Repair

  2026-11-12

  Annexin V fluorescence occupies the downstream measurement layer of the reported ENO1 cardiac-repair study. It can indicate cell-surface phosphatidylserine exposure associated with dying cells, but it does not independently establish apoptosis, the ENO1–lactate–KLF4 mechanism, or therapeutic efficacy.

• ENO1, Macrophage Metabolism, and Cardiac Repair

  2026-11-11

  Li et al. identify ENO1 as a metabolic regulator of inflammatory macrophage behavior after myocardial infarction and connect its silencing to reduced lactate, recovery of KLF4-associated reparative programs, and improved cardiac remodeling in preclinical models. This editorial separates the mechanistic evidence from the Annexin V-based apoptosis-associated readout and defines the study’s translational limits.

• ENO1, Macrophage Metabolism and Cardiac Repair

  2026-11-11

  A preclinical study examines whether ENO1 links post-infarction macrophage metabolism to inflammatory polarization and cardiac repair. It also evaluates an acid-responsive nanocarrier designed to deliver ENO1-targeting siRNA preferentially to infarct-associated macrophages.

• ENO1, Macrophage Metabolism, and Cardiac Repair

  2026-11-10

  A preclinical study examines whether ENO1 links glycolytic remodeling to inflammatory macrophage behavior after myocardial infarction and tests an acid-responsive siRNA nanocarrier as a mechanistic intervention.

• Annexin V-PE Apoptosis Kit in Cardiac Repair

  2026-11-10

  An evidence-focused interpretation of how Annexin V fluorescence fits into the ENO1–lactate–KLF4 model of postinfarction inflammation, what the apoptosis assay can establish, and which conclusions remain unresolved.

• Annexin V-PE Apoptosis Kit and ENO1 Cardiac Repair

  2026-11-09

  Annexin V-PE reports cell-surface phosphatidylserine exposure, an apoptosis-associated state that must be interpreted in context. In Li et al.’s post-infarction study, the central mechanistic claim concerned ENO1, lactate, KLF4, and macrophage inflammatory programming. The apoptosis readout supports the downstream tissue-injury phenotype but does not, by itself, establish the upstream metabolic mechanism or therapeutic causality.

• Annexin V and Postinfarction Repair

  2026-11-09

  Annexin V fluorescence reports cell-surface phosphatidylserine exposure, offering a useful apoptosis-associated readout in studies of myocardial infarction. In the ENO1 study, that measurement must be interpreted alongside macrophage metabolism, lactate–KLF4 signaling, tissue remodeling, and cardiac function rather than treated as independent proof of mechanism.

• When Context Changes an Apoptosis Readout

  2026-11-08

  Annexin V fluorescence can make phosphatidylserine exposure visible, but its biological meaning depends on the cell population, intervention, comparator, and complementary endpoints. In postinfarction research, the readout belongs downstream of a broader ENO1–lactate–KLF4 mechanism and should not be treated as independent proof of irreversible apoptosis or therapeutic efficacy.

• Why Context Changes an Apoptosis Readout

  2026-11-07

  An Annexin V signal is a measurement of cell-surface phosphatidylserine exposure, not an isolated verdict on irreversible cell death. In the postinfarction ENO1 study, that distinction matters because the assay-related observation sits downstream of a proposed macrophage metabolic mechanism involving glycolysis, lactate, KLF4 and cardiac remodeling. Interpreting the result requires separating the reagent’s analytical role from the nanocarrier’s therapeutic design and from organ-level outcomes.

• When Context Changes an Apoptosis Result

  2026-11-06

  Annexin V fluorescence reports cell-surface phosphatidylserine exposure, but its biological meaning depends on the model, comparator, assay format, and position within the evidence chain. In postinfarction cardiac research, it can support an apoptosis-related phenotype without independently proving irreversible cell death, mechanism, or therapeutic efficacy.

• ENO1, Macrophage Metabolism, and Cardiac Repair

  2026-11-06

  A preclinical study examines ENO1 as a metabolic regulator of inflammatory macrophages after myocardial infarction and evaluates an acid-responsive nanocarrier for targeted siRNA delivery. The findings connect ENO1 silencing with altered glycolysis, lactate–KLF4 signaling, reduced inflammatory activity, and improved structural cardiac outcomes in murine models.

• 5-EdU Maps Glial Repair Signaling

  2026-11-05

  A literature-focused analysis of how 5-Ethynyl-2′-deoxyuridine fits into a mouse spinal cord injury study, and why the study’s strongest mechanistic evidence comes from convergent genetic, cellular, transcriptomic and functional measurements.

• Annexin V Readouts in Cardiac Repair

  2026-11-05

  Annexin V detects cell-surface phosphatidylserine exposure, providing a useful downstream apoptosis-associated readout in postinfarction research. In the ENO1 study, that measurement belonged to a broader causal framework linking macrophage glycolysis, lactate, KLF4, inflammation, and cardiac remodeling; it did not independently establish the mechanism or therapeutic effect.

8125 records 1/542 page Next 12345 下5页 Last page